oxandrolone has been researched along with Prader-Willi Syndrome in 3 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Prader-Willi Syndrome: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frasier, SD | 1 |
| Lippe, BM | 1 |
| Nilsson, KO | 1 |
| Holm, VA | 1 |
| Nugent, JK | 1 |
| Ruvalcaba, RH | 1 |
| Costeff, H | 1 |
1 review available for oxandrolone and Prader-Willi Syndrome
| Article | Year |
|---|---|
What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Est | 1989 |
2 other studies available for oxandrolone and Prader-Willi Syndrome
| Article | Year |
|---|---|
Short stature.
Topics: Adolescent; Child; Cushing Syndrome; Female; Growth Disorders; Growth Hormone; Humans; Hypothyroidis | 1994 |
Oxandrolone therapy in six boys with the Prader-Willi syndrome.
Topics: Adolescent; Age Factors; Body Height; Child; Child, Preschool; Growth; Humans; Male; Oxandrolone; Pr | 1989 |